SUINING, China, Feb. 8, 2012/PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), announced today its plan to launch an aggressive Investors and Public Awareness Campaign throughout 2012. Strategies and programs are designed to increase market awareness of the Company among investors, institutions, and financial analysts. To grow its market presence, the company announced that it has signed a long term contract with a global news and media company as part of this awareness campaign initiative. The company will make further appointments in this area shortly and through 2012.
Jiayin Wang, Chairman and CEO of CHRI stated: "We are most excited to confirm that we now enter our next logical phase in the business - to increase public and investor awareness of CHRI and TCM. We want to articulate our progress but most importantly our vision for alternative healthcare. Our business has grown from a developmental stage and progressing into a growth phase. We have announced our "Go Global 2012" expansion program. We also have announced an acquisition initiative we are actively at. We are now receiving many serious inquires in those areas. We want the public to know more of our unique healthcare products, research but more importantly of our vision for better healthcare and we want this message to reach a global audience. We want to attract people, talent, investors and companies to join us in this major global alternative health care trend. For an aging global population, this is a must".
Traditional Chinese medicine (TCM) pharmaceutical products, along with synthetic western pharmaceuticals, are essential to the central healthcare system in China. The industry has been and is expected to continue growing significantly. In recent years in western countries such as the U.S. and the U.K., awareness of the benefits of TCM products has become increasingly attractive.
"CHRI is capitalizing in the new trend of increased demand for alternative healthcare products from an aging population in the major global economies like USA, Japan, China, Germany and Italy, the general increasing need for healthcare, and the increasing acceptance of alternative and preventive health care worldwide. Financial analysts need to know, investors need to know, the public needs to know. It is our duty to create this awareness. And the more we do, the more everyone benefits especially our shareholders," added Jiayin Wang, the Chairman and CEO of CHRI.
About CHRI
China Health Resource, Inc. engages in the development, manufacturing, processing, marketing and sale of raw and pharmaceutical TCM products including Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae and is the only the provider of GAP quality DAR in the People's Republic of China under the registered Trademark Chuan Baizhi™. DAR, which is also known as "Bai Zhi" in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The Company's DAR-related products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of which are sold through regional distributors. The Company was founded in 2001 and is based in Suining, Sichuan Province.
For more information visit www.chinahealthresource.com
Certain statements in this document regarding financial matters, other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words "believe", "expect", "anticipate", "optimistic", "intend", "will", and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.